Crossmark

Antiseptic efficacy and plasma chlorhexidine levels following two different methods of application of 1% aqueous chlorhexidine gluconate for skin disinfection in preterm newborns: a randomized controlled trial

Crossref DOI link: https://doi.org/10.1038/s41372-024-02122-y

Published Online: 2024-09-20

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dalai, Richie https://orcid.org/0000-0001-7342-5307
Mohapatra, Sarita

Velpandian, Thirumurthy

Sankar, Jeeva https://orcid.org/0000-0003-1474-1451
Thukral, Anu

Verma, Ankit https://orcid.org/0000-0003-3962-944X
Bajpai, Minu

Dhinakaran, R. https://orcid.org/0000-0002-9916-8633
Tousifullah, Mohammad

Agarwal, Ramesh https://orcid.org/0000-0001-6208-3057
License Information

Text and Data Mining valid from 2024-09-20

Version of Record valid from 2024-09-20
More Information

Article History

Received: 5 June 2024

Revised: 7 September 2024

Accepted: 13 September 2024

First Online: 20 September 2024

Competing interests

: The authors declare no competing interests.

: This study protocol was reviewed and approved by the Institutional Ethics Committee of the All India Institute of Medical Sciences, New Delhi with approval number IECPG-429/26.08.2020, RT-20/ 23.09.2020 and was prospectively registered in Clinical Trials Registry- India (CTRI) with registration number CTRI/2020/10/028719.

: Written informed consent was obtained from parents/legal guardians for the neonates to participate in the study.

Document is current

Any future updates will be listed below